Oncolytic virotherapy of breast cancer
Authors:
- Andreas D. HartkopfAHAndreas D. Hartkopf
- Tanja FehmTFTanja Fehm
- Diethelm WallwienerDWDiethelm Wallwiener
- Ulrich M. LauerULUlrich M. Lauer
- 1 October 2011
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 123 (1) , 164-171
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Oncolytic Adenovirus Expressing Soluble TGFβ Receptor II-Fc-mediated Inhibition of Established Bone Metastases: A Safe and Effective Systemic Therapeutic Approach for Breast CancerMolecular Therapy, 2011
- Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SACancer Gene Therapy, 2010
- Susceptibility of breast cancer cells to an oncolytic matrix (M) protein mutant of vesicular stomatitis virusCancer Gene Therapy, 2010
- Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer modelBreast Cancer Research and Treatment, 2009
- A modified hTERT promoter-directed oncolytic adenovirus replication with concurrent inhibition of TGFβ signaling for breast cancer therapyCancer Gene Therapy, 2009
- Targeting Cancer-initiating Cells With Oncolytic VirusesMolecular Therapy, 2009
- Oncolytic Reovirus Effectively Targets Breast Cancer Stem CellsMolecular Therapy, 2009
- Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBMMolecular Therapy, 2009
- Real‐time intraoperative detection of melanoma lymph node metastases using recombinant vaccinia virus GLV‐1h68 in an immunocompetent animal modelInternational Journal of Cancer, 2008
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997